Member Info for topsharepicks

What's the price increase of gold in situ for every $50 rise in gold guys!

Gold up $50 in 24 hours

Nm

Big rises again overnight especially silver

gold surging has to give KEFI the boost

GOLD $1842!!!!

chipping away at 1.8p soon as that breaks 2.5p in a flash

PV and GOLD just about to break higher !!!!!

COPD!!!! Is their any read across why the recent investment in Verona???? I say there is similarities treating COPD and Covid 19!

Dr Phillip Monk joined Synairgen in October 2006 as Head of Bioscience Development and was appointed to the Board as Chief Scientific Officer in September 2009. Phillip was previously Director of the Respiratory and Inflammation Biology group at Cambridge Antibody Technology (‘CAT’) and led the scientific development of tralokinumab, an anti-IL-13 antibody being developed for the treatment of severe asthma.

Prior to joining CAT, he worked at Bayer AG within the respiratory disease therapeutic area, focusing on the development of novel therapies for asthma, COPD and cystic fibrosis.

board appointment a good sign RAB clearly in for the longer ride to riches!

Best class 1 nickel is what AMC have

https://www.blackmountainmetals.com/high-quality-battery-grade-nickel/

https://www.thebalance.com/the-10-biggest-nickel-producers-2339731

It's where the demand will be

https://www.google.com/amp/s/seekingalpha.com/amp/article/4246690-top-5-nickel-producers-and-smaller-producers-to-consider

Nickel can only go much higher especially good nickel

trying to spoof buyers!!!!!

Thin liquidity the funders arent selling until this clears stage three!

So stock is actually tight and can see £1.25 easy target then on to £2

if it clears stage 3 trials BOOOOOOMMMMMM

is funded to stage 3 completion then BOOM if it clears that hurdle!

combo ill post where i like when i like!

This is going to smash £1

Near target £1.25
Medium £2
Ultimate target £5-£10

miner biggest riser this last week

close above £1 imo lets see

what folks here dont get even the supposed experts LOL

this is funded for stage 3!

end of if they jump that hurdle £5 possible easy

Verona Pharma intends to use the net proceeds from the Financing primarily to fund its Phase 3 clinical program ENHANCE (Ensifentrine as a Novel inHAled Nebulized COPD thErapy) in chronic obstructive pulmonary disease (COPD) and for general corporate purposes. The Phase 3 clinical trials are planned to start later in 2020.

“We are extremely pleased to have received support from this group of highly experienced life science investors who understand the potential benefit of ensifentrine for patients with COPD,” said David Zaccardelli, Pharm. D., President and CEO of Verona Pharma. “With this financing we plan to initiate our Phase 3 ENHANCE clinical trials later this year and expect to support our programs into 2023. This important milestone brings us closer to our goal of ensuring ensifentrine is available for millions of COPD patients who urgently need additional treatment options.”